“We feel like we got the old Bryce back, he’s not hindered by anything anymore. Hyperbaric Oxygen has definitely changed our lives and our sons. It’s such a relief as a parent to be able to see your child just perform and do all of the things he loves to do.”
Bryce was a lively and energetic child until he was diagnosed with ulcerative colitis at the age of six. This autoimmune disease, similar to Crohn’s disease, affects the colon and intestines. Bryce’s condition took a toll on his energy levels, causing him to tire easily and miss school and games. His parents embarked on a holistic journey, trying various herbs, dietary restrictions, and medications to manage his condition. However, these methods provided only temporary relief, and the fear of resorting to surgery loomed large. It was during this challenging time that they discovered Hyperbaric Oxygen Therapy (HBOT) as a potential solution. The treatment at Extivita made a significant difference, allowing Bryce to come off medications and regain his health.
Ulcerative colitis is an autoimmune disease that affects the colon and intestines, causing inflammation and ulcers. For Bryce, this condition severely impacted his energy levels, making him easily fatigued and causing him to miss school and games. The disease can also lead to various complications, including severe dehydration, inflammation of the liver, and increased risk of colon cancer.
Steve had been experiencing post-concussion headaches that affected his daily life. After starting the HBOT sessions, he noticed a complete cessation of these headaches. The therapy helped in accelerating the healing of his brain tissue, thus alleviating the symptoms of his multiple concussions.
Bryce’s condition had reached a point where surgical intervention, such as the removal of the colon, was being considered. However, the successful treatment with HBOT eliminated the need for such drastic measures, allowing Bryce to retain his colon and avoid the potential complications and lifestyle changes associated with surgery.